STOCK TITAN

Henry Schein, Inc. Stock Price, News & Analysis

HSIC Nasdaq

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.

Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.

Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.

Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.

In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.

For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.

Rhea-AI Summary

Henry Schein, the leading provider of health care solutions for dental and medical practitioners, will present virtually at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021, at 10:30 am Eastern time. The presentation will be available via live webcast at www.henryschein.com/IRwebcasts, with a replay accessible afterward. As a FORTUNE 500 Company, Henry Schein operates in 32 countries, serving over 1 million customers with more than 300 solutions for improved operational success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
conferences
-
Rhea-AI Summary

Henry Schein, the leading provider of health care solutions, will release its third quarter 2021 financial results before the market opens on November 2, 2021. A live webcast of its earnings conference call will begin at 10:00 a.m. Eastern time the same day. Key speakers include Stanley M. Bergman, Chairman and CEO, and Steven Paladino, CFO. Investors can access the call at www.henryschein.com/IRwebcasts. Henry Schein operates globally with over 21,000 team members and reported sales of $10.1 billion in 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
conferences earnings
-
Rhea-AI Summary

Henry Schein supports a coalition of physician organizations urging the Biden Administration to expedite access to COVID-19 vaccines for primary-care physicians. CEO Stanley M. Bergman highlighted ongoing vaccination challenges in communities of color and rural areas, emphasizing the role of trusted office-based physicians in addressing vaccine hesitancy. The push aims to close vaccination gaps as the CDC updates guidance allows for simultaneous administration of flu and COVID-19 vaccines. The company continues to focus on health equity amidst efforts to improve vaccine distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
none
-
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC) launched its 24th annual ‘Back to School’ program, providing backpacks filled with supplies to nearly 4,500 children across 22 locations in the U.S., Canada, Spain, and Ireland. Since 1998, the initiative has supported over 60,000 children. The program underscores the company's commitment to corporate social responsibility through Henry Schein Cares. Executive VP Gerry Benjamin highlighted the program's adaptability during the pandemic, emphasizing the importance of helping children return to school with confidence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
none
Rhea-AI Summary

Henry Schein, Inc. has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. Graham will enhance communications with investors and oversee key financial initiatives. With extensive experience in finance management, he previously served as CFO of Henry Schein's Global Dental Group. The company, a leader in health care solutions, operates globally, serving over 1 million customers. In 2020, Henry Schein generated $10.1 billion in sales, growing at a compound annual rate of approximately 12% since becoming public in 1995.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
none
-
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC) has announced a new organizational structure to enhance operational efficiency and customer experience in the dental and medical distribution sectors. The company will establish two key groups: the North America Distribution Group and the International Distribution Group, led by seasoned executives. Additionally, three specialty product areas will focus on higher-margin markets, including Henry Schein One for dental software solutions. The changes will not incur restructuring charges and aim to leverage functions and processes across the business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of healthcare solutions, announced its participation in two investor conferences in September 2021. The company will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. ET, and the Baird 2021 Virtual Global Healthcare Conference on September 14, 2021, at 12:50 p.m. ET. Live webcasts will be available on the company's website, with replays accessible afterward. Henry Schein serves over 1 million customers globally, emphasizing operational success and clinical outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
conferences

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $75.34 as of April 10, 2026.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 8.7B.